ACE2 and Rare hereditary thrombophilia: The intricate interplay between SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2) receptors, triggering hypercoagulability and thrombophilia, elucidates the heightened risk of acute ischemic stroke [6].